ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,407Medicare Part D Prescriptions Filled, Including Refills

Rank: 157 out of 670

$671K Total Retail Price of All Prescriptions

Rank: 110 out of 670

319 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 319 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 319 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,170 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
OMEPRAZOLE 282 254 1 5
LISINOPRIL 274 221 2 3
FUROSEMIDE 273 229 3 6
LEVOTHYROXINE SODIUM 268 237 4 2
HYDROCODONE-ACETAMINOPHEN 257 154 S3 5 1
OXYCODONE HCL 208 124 S2 6 72
METOPROLOL TARTRATE 182 152 7 9
PRAVASTATIN SODIUM 171 140 8 19
WARFARIN SODIUM 170 163 9 13
CARVEDILOL 162 146 10 29
FLUOXETINE HCL 158 116 11 55
AMLODIPINE BESYLATE 157 150 12 7
LOVASTATIN 137 126 13 44
MORPHINE SULFATE ER 127 15 S2 14 104
METFORMIN HCL 126 99 15 8
POTASSIUM CHLORIDE 118 96 16 16
LANTUS 110 70 17 58
ATENOLOL 108 100 18 17
SIMVASTATIN 106 85 19 4
CLOPIDOGREL 99 89 20 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 79 21 27
LANTUS SOLOSTAR 92 85 22 98
PREDNISONE 87 75 23 40
CHLORTHALIDONE 86 70 24 240
PLAVIX 86 74 24 34
METOPROLOL SUCCINATE 85 85 26 12
GABAPENTIN 85 57 26 11
CIPROFLOXACIN HCL 82 59 28 60
ISOSORBIDE MONONITRATE ER 80 72 29 45
AZITHROMYCIN 78 62 30 35
OXYCODONE-ACETAMINOPHEN 76 38 S2 31 77
ATORVASTATIN CALCIUM 75 46 32 15
NORTRIPTYLINE HCL 73 53 33 260
FENTANYL 72 49 S2 34 76
PROAIR HFA 70 46 35 28
NYSTATIN 69 63 36 139
CYCLOBENZAPRINE HCL 67 41 R 37 61
TRAZODONE HCL 65 42 38 39
DONEPEZIL HCL 64 63 39 31
OXYCODONE HCL-ACETAMINOPHEN 62 31 S2 40 71
NEXIUM 61 37 41 14
PAROXETINE HCL 61 57 41 52
DILTIAZEM 24HR ER 60 57 43 122
PRANDIN 59 40 44 350
RANITIDINE HCL 57 42 45 25
HYDROCHLOROTHIAZIDE 54 47 46 10
TAMSULOSIN HCL 54 31 46 30
PEN NEEDLE 52 50 48 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.